2
|
Tzoupis H, Nteli A, Androutsou ME, Tselios T. Gonadotropin-Releasing Hormone and GnRH Receptor: Structure, Function and Drug Development. Curr Med Chem 2021; 27:6136-6158. [PMID: 31309882 DOI: 10.2174/0929867326666190712165444] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2019] [Revised: 06/18/2019] [Accepted: 06/19/2019] [Indexed: 01/11/2023]
Abstract
BACKGROUND Gonadotropin-Releasing Hormone (GnRH) is a key element in sexual maturation and regulation of the reproductive cycle in the human organism. GnRH interacts with the pituitary cells through the activation of the Gonadotropin Releasing Hormone Receptors (GnRHR). Any impairments/dysfunctions of the GnRH-GnRHR complex lead to the development of various cancer types and disorders. Furthermore, the identification of GnRHR as a potential drug target has led to the development of agonist and antagonist molecules implemented in various treatment protocols. The development of these drugs was based on the information derived from the functional studies of GnRH and GnRHR. OBJECTIVE This review aims at shedding light on the versatile function of GnRH and GnRH receptor and offers an apprehensive summary regarding the development of different agonists, antagonists and non-peptide GnRH analogues. CONCLUSION The information derived from these studies can enhance our understanding of the GnRH-GnRHR versatile nature and offer valuable insight into the design of new more potent molecules.
Collapse
Affiliation(s)
| | - Agathi Nteli
- Department of Chemistry, University of Patras, Rion GR-26504, Greece
| | - Maria-Eleni Androutsou
- Vianex S.A., Tatoiou Str., 18th km Athens-Lamia National Road, Nea Erythrea 14671, Greece
| | - Theodore Tselios
- Department of Chemistry, University of Patras, Rion GR-26504, Greece
| |
Collapse
|
5
|
Varamini P, Rafiee A, Giddam AK, Mansfeld FM, Steyn F, Toth I. Development of New Gonadotropin-Releasing Hormone-Modified Dendrimer Platforms with Direct Antiproliferative and Gonadotropin Releasing Activity. J Med Chem 2017; 60:8309-8320. [DOI: 10.1021/acs.jmedchem.6b01771] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Affiliation(s)
- Pegah Varamini
- School
of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland 4072, Australia
| | - Amirreza Rafiee
- School
of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland 4072, Australia
| | - Ashwini Kumar Giddam
- School
of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland 4072, Australia
| | - Friederike M. Mansfeld
- School
of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland 4072, Australia
| | - Frederik Steyn
- The
University of Queensland Centre for Clinical Research and the School
of Biomedical Sciences, The University of Queensland, St. Lucia, Queensland 4072, Australia
| | - Istvan Toth
- School
of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland 4072, Australia
- School
of Pharmacy, The University of Queensland, Woollongabba, Queensland 4102, Australia
- Institute
for Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4067, Australia
| |
Collapse
|
6
|
Varamini P, Mansfeld FM, Giddam AK, Steyn F, Toth I. New gonadotropin-releasing hormone glycolipids with direct antiproliferative activity and gonadotropin-releasing potency. Int J Pharm 2017; 521:327-336. [PMID: 28232269 DOI: 10.1016/j.ijpharm.2017.02.054] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2016] [Revised: 02/10/2017] [Accepted: 02/19/2017] [Indexed: 11/19/2022]
Affiliation(s)
- Pegah Varamini
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.
| | - Friederike M Mansfeld
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia
| | - Ashwini Kumar Giddam
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia
| | - Frederik Steyn
- The University of Queensland Centre for Clinical Research and the School of Biomedical Sciences, Brisbane, Australia
| | - Istvan Toth
- School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia; School of Pharmacy, The University of Queensland, Brisbane, Australia; Institute for Molecular Biosciences, The University of Queensland, Brisbane, Australia
| |
Collapse
|
7
|
Chen CC, Chen CW, Lin PH, Chou JC, Weng TC, Jian CY, Hu S, Lai WH, Lieu FK, Wang SW, Wang PS. Interactive Effect of Corticosterone and Lactate on Regulation of Testosterone Production in Rat Leydig Cells. J Cell Physiol 2017; 232:2135-2144. [PMID: 27886378 DOI: 10.1002/jcp.25700] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2016] [Accepted: 11/21/2016] [Indexed: 11/11/2022]
Abstract
The increasing intensity of exercise enhanced corticosterone and lactate production in both humans and rodents. Our previous studies also demonstrated that lactate could stimulate testosterone production in vivo and in vitro. However, the production of testosterone in response to combined corticosterone and lactate on Leydig cells, and underlying molecular mechanisms are remained unclear. This study investigated the changes in testosterone levels of Leydig cells upon exposure to lactate, corticosterone or combination of both, and revealed the detailed mechanisms. Leydig cells were isolated from rat testes, and treated with different concentrations of lactate (2.5-20 mM), cortiosterone (10-9 -10-4 M) and lactate plus corticosterone. The production of testosterone were assayed by radioimmunoassay, and the key molecular proteins, including luteinizing hormone receptor (LHR), protein kinase A (PKA), steroidogenic acute regulatory protein (StAR), and cholesterol P450 side-chain cleavage enzyme (P450scc) involved in testosterone production were performed by Western blot. Results showed that testosterone levels were significantly increased with lactate, while decresed with corticosterone and lactate plus corticosterone treatment. Protein expressions of LHR and P450scc were upregulated with lactate treatment. However, PKA and P450scc were downregulated by lactate plus corticosterone treatment. This downregulation was followed by decreased testoterone levels in Leydig cells. Furthermore, acetylated cAMP, which activates testosterone production was increased with lactate, but not altered by conrtiosterone. Our findings conclude that corticosterone may interfere with lactate, and restrict lactate-stimulated testosterone production in Leydig cells. J. Cell. Physiol. 232: 2135-2144, 2017. © 2016 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Chih-Chieh Chen
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China
| | - Chien-Wei Chen
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China
| | - Po-Han Lin
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China
| | - Jou-Chun Chou
- Medical Center of Aging Research, China Medical University Hospital, Taichung, Taiwan, Republic of China.,Department of Life Sciences, National Chung-Hsing University, Taichung, Taiwan, Republic of China
| | - Ting-Chun Weng
- Medical Center of Aging Research, China Medical University Hospital, Taichung, Taiwan, Republic of China
| | - Cai-Yun Jian
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China
| | - Sindy Hu
- Aesthetic Medical Center, Department of Dermatology, Chang-Gung Memorial Hospital, Taoyuan, Taiwan, Republic of China.,Department of Medicine, College of Medicine, Chang-Gung University, Taoyuan, Taiwan, Republic of China
| | - Wei-Ho Lai
- Department of Rehabilitation, Cheng-Hsin General Hospital, Taipei, Taiwan, Republic of China
| | - Fu-Kong Lieu
- Department of Rehabilitation, Cheng-Hsin General Hospital, Taipei, Taiwan, Republic of China
| | - Shyi-Wu Wang
- Department of Life Sciences, National Chung-Hsing University, Taichung, Taiwan, Republic of China.,Department of Physiology and Pharmacology, College of Medicine, Chang-Gung University, Taoyuan, Taiwan, Republic of China
| | - Paulus S Wang
- Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China.,Medical Center of Aging Research, China Medical University Hospital, Taichung, Taiwan, Republic of China.,Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan, Republic of China.,Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China
| |
Collapse
|
9
|
Thevis M, Kuuranne T, Walpurgis K, Geyer H, Schänzer W. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal 2016; 8:7-29. [PMID: 26767774 DOI: 10.1002/dta.1928] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2015] [Revised: 11/10/2015] [Accepted: 11/10/2015] [Indexed: 12/30/2022]
Abstract
The aim of improving anti-doping efforts is predicated on several different pillars, including, amongst others, optimized analytical methods. These commonly result from exploiting most recent developments in analytical instrumentation as well as research data on elite athletes' physiology in general, and pharmacology, metabolism, elimination, and downstream effects of prohibited substances and methods of doping, in particular. The need for frequent and adequate adaptations of sports drug testing procedures has been incessant, largely due to the uninterrupted emergence of new chemical entities but also due to the apparent use of established or even obsolete drugs for reasons other than therapeutic means, such as assumed beneficial effects on endurance, strength, and regeneration capacities. Continuing the series of annual banned-substance reviews, literature concerning human sports drug testing published between October 2014 and September 2015 is summarized and reviewed in reference to the content of the 2015 Prohibited List as issued by the World Anti-Doping Agency (WADA), with particular emphasis on analytical approaches and their contribution to enhanced doping controls.
Collapse
Affiliation(s)
- Mario Thevis
- Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany.,European Monitoring Center for Emerging Doping Agents, Cologne/Bonn, Germany
| | - Tiia Kuuranne
- Doping Control Laboratory, United Medix Laboratories, Höyläämötie 14, 00380, Helsinki, Finland
| | - Katja Walpurgis
- Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany
| | - Hans Geyer
- Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany
| | - Wilhelm Schänzer
- Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Am Sportpark Müngersdorf 6, 50933, Cologne, Germany
| |
Collapse
|